(NewsDirect)
Valeo Pharma CEO Steve Saviuk joinedSteve Darling from Proactive to share news the company has releasedits financial results for the fourth quarter and year-ended October31, 2022.
Saviuk told Proactive thecompany saw record quarterly revenue of $12.7 million in 4Q 2022,which is up 274% year over year. Valeo also reported record annualrevenues of $27.7 million for 2022, compared to $13.6 million in 2021,up 105%.
Saviuk also shared more details about what driven thegrowth in revenue and what is planned in 2023 to fuel the momentum.
ContactDetails
Proactive
+1 347-449-0879
na-editorial@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.